New Key Statistics Module, Z-Score and F-Score
NYSE:BIO Key Ratios
| Market Cap $ M | 9,267.62 |
| Enterprise Value $ M | 8,978.28 |
| P/E(ttm) | -- |
| PE Ratio without NRI | 30.77 |
| Forward PE Ratio | 30.18 |
| Price/Book | 1.39 |
| Price/Sales | 3.73 |
| Price/Free Cash Flow | 53.97 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 2,562.00 |
| EPS (TTM) $ | -47.03 |
| Beneish M-Score | -2.47 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -5.34 |
| EV-to-EBITDA | -5.86 |
| PEG | -- |
| Shares Outstanding M | 27.87 |
| Net Margin (%) | -51.73 |
| Operating Margin % | 12.97 |
| Pre-tax Margin (%) | -67.50 |
| Quick Ratio | 4.63 |
| Current Ratio | 6.28 |
| ROA % (ttm) | -11.34 |
| ROE % (ttm) | -16.00 |
| ROIC % (ttm) | 2.63 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.99 |
BIO Number of Guru Trades
BIO Volume of Guru Trades
Gurus Latest Trades with NYSE:BIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:BIO is held by these investors
Total 6
Bio-Rad Laboratories Inc Insider Transactions
No Available Data
News about NYSE:BIO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers